Stay updated on Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.
Latest updates to the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check10 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check46 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference1%
- Check61 days agoChange DetectedSeveral key resources related to genetics and cancer, including MedlinePlus and NIH links, have been removed, which may impact access to important health information.SummaryDifference3%
- Check68 days agoChange DetectedNew resources related to bladder cancer, transitional cell carcinoma, and urethral cancer have been added, along with links to drug information and various health organizations.SummaryDifference0.3%
Stay in the know with updates to Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.